Rain Oncology Inc (DELISTED) (RAIN:DL)
1.21
0.00 (0.00%)
USD |
NASDAQ |
Jan 26, 16:00
Rain Oncology Total Assets (Quarterly): 82.06M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 82.06M |
| June 30, 2023 | 91.72M |
| March 31, 2023 | 114.18M |
| December 31, 2022 | 135.18M |
| September 30, 2022 | 94.64M |
| June 30, 2022 | 110.66M |
| Date | Value |
|---|---|
| March 31, 2022 | 127.78M |
| December 31, 2021 | 147.14M |
| September 30, 2021 | 158.53M |
| June 30, 2021 | 174.55M |
| March 31, 2021 | 56.50M |
| December 31, 2020 | 61.08M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
56.50M
Minimum
Mar 2021
174.55M
Maximum
Jun 2021
112.83M
Average
112.42M
Median
Total Assets (Quarterly) Benchmarks
| Icosavax Inc (DELISTED) | 251.30M |
| AbbVie Inc | 148.87B |
| Cerevel Therapeutics Holdings Inc | 1.127B |
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.54M |
| Shareholders Equity (Quarterly) | 67.52M |